CN Patent

CN109310630A — 用于治疗感染的组合物、系统、试剂盒和方法

Assigned to NVN Liquidation Inc · Expires 2019-02-05 · 7y expired

What this patent protects

本文提供用于治疗病毒、细菌、原生动物和/或真菌(例如，甲癣和/或足癣)感染的组合物、系统、试剂盒和方法。

USPTO Abstract

本文提供用于治疗病毒、细菌、原生动物和/或真菌(例如，甲癣和/或足癣)感染的组合物、系统、试剂盒和方法。

Drugs covered by this patent

berdazimer-sodium (BERDAZIMER SODIUM)

Patent Metadata

Patent number: CN109310630A
Jurisdiction: CN
Classification: —
Expires: 2019-02-05
Drug substance claim: No
Drug product claim: No
Assignee: NVN Liquidation Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.